Research ArticleVACCINES

Nucleoside-modified mRNA encoding HSV-2 glycoproteins C, D, and E prevents clinical and subclinical genital herpes

See allHide authors and affiliations

Science Immunology  20 Sep 2019:
Vol. 4, Issue 39, eaaw7083
DOI: 10.1126/sciimmunol.aaw7083

Article Information

vol. 4 no. 39

PubMed: 
Published By: 
History: 
  • Received January 17, 2019
  • Revision received April 16, 2019
  • Accepted July 30, 2019
  • .

Author Information

  1. Sita Awasthi1,
  2. Lauren M. Hook1,
  3. Norbert Pardi1,
  4. Fushan Wang1,
  5. Arpita Myles2,
  6. Michael P. Cancro2,
  7. Gary H. Cohen3,
  8. Drew Weissman1 and
  9. Harvey M. Friedman1,*
  1. 1Infectious Disease Division, Department of Medicine, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA.
  2. 2Department of Pathology and Laboratory Medicine, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA.
  3. 3Microbiology Department, School of Dental Medicine, University of Pennsylvania, Philadelphia, PA, USA.
  1. *Corresponding author. Email: hfriedma{at}pennmedicine.upenn.edu

Altmetric

Article usage

Article usage: September 2019 to December 2020

AbstractFullPdf
Sep 2019227116551228
Oct 20192230898210
Nov 201912434630
Dec 201910324523
Jan 202013179739
Feb 20208397537
Mar 20209394023
Apr 20208202216
May 20209982513
Jun 2020659176
Jul 20206272312
Aug 20204592410
Sep 202030929045
Oct 20201149962
Nov 20201153388
Dec 202026313

Stay Connected to Science Immunology

Navigate This Article